Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test
Launched by THE CLEVELAND CLINIC · Jun 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, low-cost test called ScreenFire that allows women to collect their own samples to check for the Human Papilloma Virus (HPV), which can lead to cervical cancer. The goal is to see how well this self-collected test works compared to the standard test, which is done by a healthcare provider. The study is currently looking for women aged 30 to 59 who have not had cervical cancer screening in the last two years and are not pregnant or have had a hysterectomy.
If you join the trial, you will be able to use the ScreenFire test in a single visit, making it easier and more convenient. Participants will help researchers understand if this new test can be a reliable option for HPV screening. This could lead to better and more accessible cervical cancer prevention for women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female, aged 30-59
- Exclusion Criteria:
- • Pregnancy at time of colposcopy/biopsy
- • Hysterectomy with surgically absent cervix
- • Cervical cancer screening in the past two years
- • Prior diagnosis or treatment of invasive cervical cancer
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Salvador, , El Salvador
Patients applied
Trial Officials
Miriam Cremer, M.D.
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials